cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Sqz Biotechnologies Co
2 own
4 watching
Current Price
$0.6
$0.03
(4.9%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
17.69M
52-Week High
52-Week High
3.98
52-Week Low
52-Week Low
0.53
Average Volume
Average Volume
0.04M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization17.69M
icon52-Week High3.98
icon52-Week Low0.53
iconAverage Volume0.04M
iconDividend Yield--
iconP/E Ratio--
What does the Sqz Biotechnologies Co do?
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with other immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. SQZ Biotechnologies Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.
Read More
How much money does Sqz Biotechnologies Co make?
News & Events about Sqz Biotechnologies Co.
PR Newswire
5 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SQZ Biotechnologies Company - SQZ SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SQZ Biotechnologies Company - SQZ PR Newswire NEW YORK, Jan. 4, 2023 NEW YORK, Jan. 4, 2023...
Globe Newswire
5 months ago
NEW YORK, Jan. 01, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SQZ Biotechnologies Company (SQZ or the Company) (NYSE:SQZ). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation ...
PR Newswire
5 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SQZ Biotechnologies Company - SQZ SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SQZ Biotechnologies Company - SQZ PR Newswire NEW YORK, Dec. 26, 2022 NEW YORK, Dec. 26, 2022...
Globe Newswire
5 months ago
NEW YORK, Dec. 24, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SQZ Biotechnologies Company (SQZ or the Company) (NYSE:SQZ). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation ...
PR Newswire
5 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SQZ Biotechnologies Company - SQZ SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SQZ Biotechnologies Company - SQZ PR Newswire NEW YORK, Dec. 19, 2022 NEW YORK, Dec. 19, 2022...
Frequently Asked Questions
Frequently Asked Questions
What is Sqz Biotechnologies Co share price today?
plus_minus_icon
Can Indians buy Sqz Biotechnologies Co shares?
plus_minus_icon
How can I buy Sqz Biotechnologies Co shares from India?
plus_minus_icon
Can Fractional shares of Sqz Biotechnologies Co be purchased?
plus_minus_icon
What are the documents required to start investing in Sqz Biotechnologies Co stocks?
plus_minus_icon
What is today’s traded volume of Sqz Biotechnologies Co?
plus_minus_icon
What is today’s market capitalisation of Sqz Biotechnologies Co?
plus_minus_icon
What is the 52-Week High and Low Range of Sqz Biotechnologies Co?
plus_minus_icon
What percentage is Sqz Biotechnologies Co down from its 52-Week High?
plus_minus_icon
What percentage is Sqz Biotechnologies Co up from its 52-Week Low?
plus_minus_icon
Current Price
$0.6
$0.03
(4.9%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
SPRUCE BIOSCIENCES INC
SPRUCE BIOSCIENCES INC
$2.34
$0.02 (0.65 %)
SIGILON THERAPEUTICS INC
SIGILON THERAPEUTICS INC
$4.30
$0.10 (2.38 %)
POSEIDA THERAPEUTICS INC
POSEIDA THERAPEUTICS INC
$2.42
$0.14 (6.14 %)
ONCORUS INC
ONCORUS INC
$0.11
$-0.07 (-37.12 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
SPRUCE BIOSCIENCES INC
SPRUCE BIOSCIENCES INC
$2.34
$0.02 (0.65 %)
SIGILON THERAPEUTICS INC
SIGILON THERAPEUTICS INC
$4.30
$0.10 (2.38 %)
POSEIDA THERAPEUTICS INC
POSEIDA THERAPEUTICS INC
$2.42
$0.14 (6.14 %)
ONCORUS INC
ONCORUS INC
$0.11
$-0.07 (-37.12 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00